HER2-positive breast cancer is a type in which the cancer cells make too much of a protein called human epidermal growth factor receptor 2. Learn more.
Florida Cancer Specialists & Research Institute leaders join executive oncology peers at the Association of Value-Based Cancer Care 2025 in New York City.
FCS Top News Updates
FCS Leaders Spotlight Innovation and Collaboration at COA 2026 to Advance Community Oncology Care
Rx To Go Achieves Accreditation with ACHCRx To Go achieves ACHC re-accreditation for pharmacy with distinction in oncology.
Therapeutic PhlebotomySome conditions cause your body to overproduce red blood cells or iron. A phlebotomy will remove some of these cells.
Triple Negative Breast Cancer -Summary, Symptoms, TreatmentsTriple-negative breast cancer lacks three common receptors found in many other breast cancers: estrogen, progesterone, and HER2 protein. Learn more.
Bone Marrow BiopsyBone marrow biopsy and bone marrow aspiration are procedures to collect and examine bone marrow. Learn More.
HER2-Positive Breast Cancer – Summary, Symptoms, TreatmentsHER2-positive breast cancer is a type in which the cancer cells make too much of a protein called human epidermal growth factor receptor 2. Learn more.
FCS Clinicians Offer Insights on Optimizing Patient Outcomes at Statewide CongressFCS clinicians share expertise at the FLASCO Fall Oncology Congress to advance cancer care and improve patient outcomes.
The Path of a Patient Sample – VideoIn this video John Sodeika discusses his journey to recovery after being diagnosed with advanced gastric cancer.
FCS Leaders Convene With Executive Peers at Value-Based Cancer Care SummitFlorida Cancer Specialists & Research Institute leaders join executive oncology peers at the Association of Value-Based Cancer Care 2025 in New York City.